title: [Management of patients with intermittent claudication].
abstract: Management of patients with intermittent claudication must be first the treatment of the atherosclerosis process: cessation of smoking, antiplatelet therapy, betablockers, angiotensin-converting-enzyme inhibitor and cholesterol lowering in order to have a LDL cholesterol < 1 g/L. Treatment of intermittent claudication depends of the arterial lesions. If an endovascular procedure is feasible and safe, iliac stenosis or short iliac occlusion, it permits a spectacular improvement. Most often only medical treatment with physical training is advisable. Surgical revascularisation is rarely justified in patients with intermittent claudication.
authors.affiliation: Pôle cardio-vasculaire, Hôpital européen Georges Pompidou, 75908 Paris 15. jean-noel.fiessinger@egp.aphp.fr
authors.forename: Jean-Noël
authors.initials: JN
authors.lastname: Fiessinger
authors.forename: Marc
authors.initials: M
authors.lastname: Sapoval
authors.forename: Pierre
authors.initials: P
authors.lastname: Julia
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017130:Angioplasty; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015642:Radiology, Interventional
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D010975:Platelet Aggregation Inhibitors